|
|
|
Anemia Clinical Trials, Diagnosis, and Treatment |
|
Thank you for your interest in clinical trials for Anemia.
Please click "Search" to find Anemia clinical trials and medical research
studies or read below for information on Anemia diagnosis and treatment.
If you receive too many study listings you may enter your zip code to find the
locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 4 studies:
|
|
|
|
|
Results from other databases:
|
|
Your search returned over 250 results. The top 250 results are being displayed. Please use
additional keywords or decrease the search distance. |
|
Your search returned 250 studies:
- A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease - NCT00830037-46202
Conditions: Chronic Kidney Disease - Iron-Deficiency Anemia
Location: Indianapolis, IN
- A Phase II Study of Umbilical Cord Blood Transplantation - NCT00676806-02111
Conditions: Leukemia - Lymphoma - Multiple Myeloma - Aplastic Anemia
Location: Boston, MA
- A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Aplastic Anemia Patients With Immunosuppressive-Therapy Refractory Thrombocytopenia - NCT00922883-20892
Conditions: Anemia, Aplastic - Anemia, Hypoplastic - Thrombocytopenia
Location: Bethesda, MD
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-01107
Conditions: Anemia - Chronic Kidney Disease
Location: Springfield, MA
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-11355
Conditions: Anemia - Chronic Kidney Disease
Location: Flushing, NY
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-11501
Conditions: Anemia - Chronic Kidney Disease
Location: Mineola, NY
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-29118
Conditions: Anemia - Chronic Kidney Disease
Location: Orangeburg, SC
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-33028
Conditions: Anemia - Chronic Kidney Disease
Location: Pembroke Pines, FL
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-33173
Conditions: Anemia - Chronic Kidney Disease
Location: Miami, FL
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-33313
Conditions: Anemia - Chronic Kidney Disease
Location: Lauderdale Lakes, FL
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-34108
Conditions: Anemia - Chronic Kidney Disease
Location: Naples, FL
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-37205
Conditions: Anemia - Chronic Kidney Disease
Location: Nashville, TN
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-46545
Conditions: Anemia - Chronic Kidney Disease
Location: Mishawaka, IN
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-61603
Conditions: Anemia - Chronic Kidney Disease
Location: Peoria, IL
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-76015
Conditions: Anemia - Chronic Kidney Disease
Location: Arlington, TX
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-77054
Conditions: Anemia - Chronic Kidney Disease
Location: Houston, TX
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-78215
Conditions: Anemia - Chronic Kidney Disease
Location: San Antobio, TX
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-83642
Conditions: Anemia - Chronic Kidney Disease
Location: Meridian, ID
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-90022
Conditions: Anemia - Chronic Kidney Disease
Location: Los Angeles, CA
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-90603
Conditions: Anemia - Chronic Kidney Disease
Location: Whittier, CA
- A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis - NCT00968617-92123
Conditions: Anemia - Chronic Kidney Disease
Location: San Diego, CA
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-11355
Conditions: Anemia - Chronic Kidney Disease
Location: Flushing, NY
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-14221
Conditions: Anemia - Chronic Kidney Disease
Location: Williamsville, NY
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-22030
Conditions: Anemia - Chronic Kidney Disease
Location: Farifax, VA
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-23116
Conditions: Anemia - Chronic Kidney Disease
Location: Mechanicsville,, VA
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-33028
Conditions: Anemia - Chronic Kidney Disease
Location: Pembroke Pines, FL
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-33156
Conditions: Anemia - Chronic Kidney Disease
Location: Pinecrest, FL
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-43606
Conditions: Anemia - Chronic Kidney Disease
Location: Toledo, OH
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-45267
Conditions: Anemia - Chronic Kidney Disease
Location: Cincinnati, OH
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-60031
Conditions: Anemia - Chronic Kidney Disease
Location: Gurnee, IL
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-70723
Conditions: Anemia - Chronic Kidney Disease
Location: Paramount, CA
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-76015
Conditions: Anemia - Chronic Kidney Disease
Location: Arlington, TX
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-77054
Conditions: Anemia - Chronic Kidney Disease
Location: Houston, TX
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-80002
Conditions: Anemia - Chronic Kidney Disease
Location: Arvada, CO
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-90022
Conditions: Anemia - Chronic Kidney Disease
Location: Los Angeles, CA
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-90241
Conditions: Anemia - Chronic Kidney Disease
Location: Downey, CA
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-91344
Conditions: Anemia - Chronic Kidney Disease
Location: Granada Hills, CA
- A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease - NCT00924781-92123
Conditions: Anemia - Chronic Kidney Disease
Location: San Diego, CA
- A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure - NCT00001962-20892
Conditions: Aplastic Anemia - Pure Red Cell Aplasia - Diamond Blackfan Anemia
Location: Bethesda, MD
- Alemtuzumab to Treat Severe Aplastic Anemia - NCT00195624-20892
Conditions: Relapsed or Refractory Severe Aplastic Anemia - Severe Aplastic Anemia
Location: Bethesda, MD
- Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders - NCT00301834-53792
Conditions: Congenital Amegakaryocytic Thrombocytopenia - Diamond-Blackfan Anemia - Leukemia - Myelodysplastic Syndromes - Severe Congenital Neutropenia
Location: Madison, WI
- Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders - NCT00301834-94115
Conditions: Congenital Amegakaryocytic Thrombocytopenia - Diamond-Blackfan Anemia - Leukemia - Myelodysplastic Syndromes - Severe Congenital Neutropenia
Location: San Francisco, CA
- Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia (SAA) Using Matched Unrelated Donors and Mismatched Related Donors - NCT00578903-77030A
Conditions: Aplastic Anemia
Location: Houston, TX
- Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia (SAA) Using Matched Unrelated Donors and Mismatched Related Donors - NCT00578903-77030B
Conditions: Aplastic Anemia
Location: Houston, TX
- Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia - NCT00578266-55905
Conditions: Anemia, Aplastic
Location: Rochester, MN
- Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs - NCT00957931-35233
Conditions: Sickle Cell Disease - Thalassemia - Diamond-Blackfan Anemia
Location: Birmingham, AL
- Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs - NCT00957931-55455
Conditions: Sickle Cell Disease - Thalassemia - Diamond-Blackfan Anemia
Location: Minneapolis, MN
- An Open-Label, Single-Arm Pilot Study of the Efficacy of Erythropoietin Alfa in Improving Peak Oxygen Consumption in Elderly Subjects With Unexplained Anemia - NCT00954486-60637
Conditions: Anemia
Location: Chicago, IL
- An Open-Label, Single-Arm Pilot Study of the Efficacy of Erythropoietin Alfa in Improving Peak Oxygen Consumption in Elderly Subjects With Unexplained Anemia - NCT00954486-94304
Conditions: Anemia
Location: Palo Alto, CA
- An Open-Label, Single-Arm Pilot Study of the Efficacy of Erythropoietin Alfa in Improving Peak Oxygen Consumption in Elderly Subjects With Unexplained Anemia - NCT00954486-94305
Conditions: Anemia
Location: Stanford, CA
- Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF) - NCT00286182-10034
Conditions: Anemia
Location: New York, NY
- Anemia in the Elderly - NCT00640172-84132
Conditions: Anemia
Location: Salt Lake City, UT
- Anemia in the Elderly - NCT00640172-94304
Conditions: Anemia
Location: Palo Alto, CA
- Anemia in the Elderly - NCT00640172-94305
Conditions: Anemia
Location: Stanford, CA
- Anemia Treatment for Advanced NSCLC Patients Receiving Chemotherapy - NCT00858364-
Conditions: Non-small Cell Lung Cancer - Anemia - Cancer - Lung Cancer
Location: Tacoma, WA
- Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fanconi Anemia - NCT00590460-77030A
Conditions: Fanconi Anemia
Location: Houston, TX
- Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fanconi Anemia - NCT00590460-77030B
Conditions: Fanconi Anemia
Location: Houston, TX
- Antioxidant Therapy to Reduce Inflammation in Sickle Cell Disease - NCT01054768-94609
Conditions: Anemia, Sickle Cell
Location: Oakland, CA
- Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients - NCT00029731-94609
Conditions: Anemia, Sickle Cell - Pneumonia
Location: Oakland, CA
- Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor (GCSF) Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients With Betathalassemia Major - NCT00658385-10065
Conditions: Beta Thalassemia Major - Congenital Anemias
Location: New York, NY
- Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM1) - NCT01023035-02905
Conditions: Hepatitis C, Chronic
Location: Providence, RI
- Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM1) - NCT01023035-17604
Conditions: Hepatitis C, Chronic
Location: Lancaster, PA
- Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM1) - NCT01023035-22306
Conditions: Hepatitis C, Chronic
Location: Alexandria, VA
- Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM1) - NCT01023035-28677
Conditions: Hepatitis C, Chronic
Location: Statesville, NC
- Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM1) - NCT01023035-33414
Conditions: Hepatitis C, Chronic
Location: Wellington, FL
- Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM1) - NCT01023035-38138
Conditions: Hepatitis C, Chronic
Location: Germantown, TN
- Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM1) - NCT01023035-64131
Conditions: Hepatitis C, Chronic
Location: Kansas City, MO
- Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM1) - NCT01023035-78215
Conditions: Hepatitis C, Chronic
Location: San Antonio, TX
- Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM1) - NCT01023035-93301
Conditions: Hepatitis C, Chronic
Location: Bakersfield, CA
- Caring for Those Who Share: Improving the Health of Wisconsin Blood Donors - NCT00772083-53201
Conditions: Anemia - Colorectal Cancer
Location: Milwaukee, WI
- Chemotherapy, Antithymocyte Globulin, Total-Body Irradiation, and a Donor Umbilical Cord Blood Transplant and Donor Stem Cell Transplant in Treating Patients With Severe Aplastic Anemia or Myelodysplastic Syndromes - NCT00608413-20892
Conditions: Leukemia - Myelodysplastic Syndromes - Nonmalignant Neoplasm
Location: Bethesda, MD
- Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes - NCT00102245-20892
Conditions: Hemoglobinopathies - Hemolysis - Iron Deficiency and Overload - Anemias
Location: Bethesda, MD
- Clinical Importance of Treating Iron Overload in Sickle Cell Disease - NCT00981370-90027A
Conditions: Anemia, Sickle Cell - Transfusion Hemochromatosis
Location: Los Angeles, CA
- Clinical Importance of Treating Iron Overload in Sickle Cell Disease - NCT00981370-90027B
Conditions: Anemia, Sickle Cell - Transfusion Hemochromatosis
Location: Los Angeles, CA
- Collection and Storage of Umbilical Cord Stem Cells for Treatment of Sickle Cell Disease - NCT00012545-20892
Conditions: Healthy - Sickle Cell Anemia
Location: Bethesda, MD
- Combination Chemotherapy in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Fanconi's Anemia - NCT00258427-55455
Conditions: Fanconi Anemia - Graft Versus Host Disease
Location: Minneapolis, MN
- Conservative Versus Liberal Red Cell Transfusion in Myocardial Infarction Trial: The CRIT Pilot - NCT00126334-20010A
Conditions: Myocardial Infarction - Anemia
Location: Washington, DC
- Conservative Versus Liberal Red Cell Transfusion in Myocardial Infarction Trial: The CRIT Pilot - NCT00126334-20010B
Conditions: Myocardial Infarction - Anemia
Location: Washington, DC
- Cyclophosphamide and Antithymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing a Donor Bone Marrow Transplant - NCT00343785-07601
Conditions: Graft Versus Host Disease - Nonmalignant Neoplasm
Location: Hackensack, NJ
- Cyclophosphamide and Antithymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing a Donor Bone Marrow Transplant - NCT00343785-53226
Conditions: Graft Versus Host Disease - Nonmalignant Neoplasm
Location: Milwaukee, WI
- Cyclophosphamide and Antithymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing a Donor Bone Marrow Transplant - NCT00343785-84132
Conditions: Graft Versus Host Disease - Nonmalignant Neoplasm
Location: Salt Lake City, UT
- Cyclophosphamide and Antithymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing a Donor Bone Marrow Transplant - NCT00343785-94609
Conditions: Graft Versus Host Disease - Nonmalignant Neoplasm
Location: Oakland, CA
- Cyclophosphamide and Antithymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing a Donor Bone Marrow Transplant - NCT00343785-98109
Conditions: Graft Versus Host Disease - Nonmalignant Neoplasm
Location: Seattle, WA
- Cyclophosphamide, Alemtuzumab, Total-Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Severe Aplastic Anemia - NCT00598221-77030A
Conditions: Nonmalignant Neoplasm
Location: Houston, TX
- Cyclophosphamide, Alemtuzumab, Total-Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Severe Aplastic Anemia - NCT00598221-77030B
Conditions: Nonmalignant Neoplasm
Location: Houston, TX
- Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant - NCT00354419-98104
Conditions: Nonmalignant Neoplasm
Location: Seattle, WA
- Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant - NCT00354419-98109
Conditions: Nonmalignant Neoplasm
Location: Seattle, WA
- Cyclophosphamide, Fludarabine, and Antithymocyte Globulin Followed By Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia - NCT00630253-55455
Conditions: Fanconi Anemia - Leukemia - Myelodysplastic Syndromes - Nonmalignant Neoplasm
Location: Minneapolis, MN
- Delayed Cord Clamping in Premature Infants - NCT01018576-95817
Conditions: Hypothermia - Anemia
Location: Sacramento, CA
- Diamond Blackfan Anemia Registry (DBAR) - NCT00106015-11040
Conditions: Anemia - Blood Disease
Location: New Hyde Park, NY
- Donor Stem Cell Transplant in Treating Patients With Fanconi's Anemia - NCT00453388-98109A
Conditions: Fanconi Anemia - Graft Versus Host Disease - Leukemia - Myelodysplastic Syndromes
Location: Seattle, WA
- Donor Stem Cell Transplant in Treating Patients With Fanconi's Anemia - NCT00453388-98109B
Conditions: Fanconi Anemia - Graft Versus Host Disease - Leukemia - Myelodysplastic Syndromes
Location: Seattle, WA
- Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell Disease - NCT00600665-60612
Conditions: Anemia, Sickle Cell - Hemoglobin SC Disease
Location: Chicago, IL
- Effects Of Darbepoetin On Vascular Repair Mechanisms In Kidney Disease The DARBEPC Study - NCT00396123-48109
Conditions: Chronic Kidney Disease - Anemia
Location: Ann Arbor, MI
- Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury - NCT00313716-77030
Conditions: Anemia - Traumatic Brain Injury
Location: Houston, TX
- Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury - NCT00313716-77074
Conditions: Anemia - Traumatic Brain Injury
Location: Houston, TX
- Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA) - NCT00982007-19403
Conditions: Iron Deficiency Anemia
Location: Valley Forge, PA
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-02115
Conditions: Anemia
Location: Boston, MA
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-07503
Conditions: Anemia
Location: Paterson, NJ
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-07601
Conditions: Anemia
Location: Hackensack, NJ
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-10021
Conditions: Anemia
Location: New York, NY
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-13210
Conditions: Anemia
Location: Syracuse, NY
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-17033
Conditions: Anemia
Location: Hershey, PA
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-19104
Conditions: Anemia
Location: Philadelphia, PA
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-36604
Conditions: Anemia
Location: Mobile, AL
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-44308
Conditions: Anemia
Location: Akron, OH
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-45229
Conditions: Anemia
Location: Cincinnati, OH
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-60614
Conditions: Anemia
Location: Chicago, IL
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-71130
Conditions: Anemia
Location: Shreveport, LA
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-92868
Conditions: Anemia
Location: Orange, CA
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-94304
Conditions: Anemia
Location: Stanford, CA
- ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox - NCT00466063-94609
Conditions: Anemia
Location: Oakland, CA
- Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma - NCT00400686-44106
Conditions: Anemia - Multiple Myeloma and Plasma Cell Neoplasm
Location: Cleveland, OH
- Evaluating an Educational Program Geared for Parents and Aimed at Improving Academic Success in Children With Sickle Cell Disease - NCT00860782-33131
Conditions: Hemoglobin SC Disease - Anemia, Sickle Cell
Location: Miami, FL
- Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers - NCT00899795-97239
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Portland, OR
- Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function - NCT00981045-19403
Conditions: Iron Deficiency Anemia - Impaired Renal Function
Location: Valley Forge, PA
- Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies - NCT00038051-77030
Conditions: Acute Myeloid Leukemia - Chronic Myelomonocytic Leukemia - Myeloproliferative Disorders - Anemia, Refractory, With Excess of Blasts
Location: Houston, TX
- Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study - NCT00850018-02118
Conditions: Anemia, Sickle Cell
Location: Boston, MA
- Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study - NCT00850018-20001
Conditions: Anemia, Sickle Cell
Location: Washington, DC
- Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study - NCT00850018-27514
Conditions: Anemia, Sickle Cell
Location: Chapel Hill, NC
- Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study - NCT00850018-27710
Conditions: Anemia, Sickle Cell
Location: Durham, NC
- Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study - NCT00850018-30912
Conditions: Anemia, Sickle Cell
Location: Augusta, GA
- Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study - NCT00850018-33021
Conditions: Anemia, Sickle Cell
Location: Hollywood, FL
- Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study - NCT00850018-33136
Conditions: Anemia, Sickle Cell
Location: Miami, FL
- Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study - NCT00850018-45229
Conditions: Anemia, Sickle Cell
Location: Cincinnati, OH
- Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study - NCT00850018-45267
Conditions: Anemia, Sickle Cell
Location: Cincinnati, OH
- Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study - NCT00850018-48201
Conditions: Anemia, Sickle Cell
Location: Detroit, MI
- Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study - NCT00850018-63110
Conditions: Anemia, Sickle Cell
Location: St. Louis, MO
- Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study - NCT00850018-77555
Conditions: Anemia, Sickle Cell
Location: Galveston, TX
- Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study - NCT00850018-94117
Conditions: Anemia, Sickle Cell
Location: Baltimore, MD
- Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention Study - NCT00850018-94609
Conditions: Anemia, Sickle Cell
Location: Oakland, CA
- Fanconi Anemia Transplant Lacking Genotypically Identical Donor - NCT00850317-02115
Conditions: Fanconi Anemia
Location: Boston, MA
- Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed By Donor Bone Marrow Transplant in Treating Patients With Sickle Cell Anemia - NCT00489281-21231
Conditions: Precancerous Condition
Location: Baltimore, MD
- Fludarabine, Melphalan, Total-Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders - NCT00856388-14263
Conditions: Chronic Myeloproliferative Disorders - Fanconi Anemia - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases - Nonmalignant Neoplasm - Precancerous Condition
Location: Buffalo, NY
- Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation in Aplastic Anemia - NCT00474747-77030
Conditions: Aplastic Anemia
Location: Houston, TX
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-02114A
Conditions: Anemia, Aplastic
Location: Boston, MA
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-02114B
Conditions: Anemia, Aplastic
Location: Boston, MA
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-07601
Conditions: Anemia, Aplastic
Location: Hackensack, NJ
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-10021
Conditions: Anemia, Aplastic
Location: New York City, NY
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-14263
Conditions: Anemia, Aplastic
Location: Buffalo, NY
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-20010
Conditions: Anemia, Aplastic
Location: Washington, DC
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-23298
Conditions: Anemia, Aplastic
Location: Richmond, VA
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-27705
Conditions: Anemia, Aplastic
Location: Durham, NC
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-30322
Conditions: Anemia, Aplastic
Location: Atlanta, GA
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-32610
Conditions: Anemia, Aplastic
Location: Gainesville, FL
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-43205
Conditions: Anemia, Aplastic
Location: Columbus, OH
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-45229
Conditions: Anemia, Aplastic
Location: Cincinnati, OH
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-48109
Conditions: Anemia, Aplastic
Location: Ann Arbor, MI
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-55455
Conditions: Anemia, Aplastic
Location: Minneapolis, MN
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-57105
Conditions: Anemia, Aplastic
Location: Sioux Falls,
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-75235
Conditions: Anemia, Aplastic
Location: Dallas, TX
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-76104
Conditions: Anemia, Aplastic
Location: Fort Worth, TX
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-77030
Conditions: Anemia, Aplastic
Location: Houston, TX
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-78229
Conditions: Anemia, Aplastic
Location: San Antonio, TX
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-85016
Conditions: Anemia, Aplastic
Location: Phoenix, AZ
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-90027
Conditions: Anemia, Aplastic
Location: Los Angeles, CA
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-90095
Conditions: Anemia, Aplastic
Location: Los Angeles, CA
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-91010
Conditions: Anemia, Aplastic
Location: Duarte, CA
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-94305
Conditions: Anemia, Aplastic
Location: Stanford, CA
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-97239
Conditions: Anemia, Aplastic
Location: Portland, OR
- Fludarabine-based Conditioning for Severe Aplastic Anemia - NCT00326417-98109
Conditions: Anemia, Aplastic
Location: Seattle, WA
- Gene Function in Bone Marrow Cells From Patients With Fanconi Anemia and From Healthy Participants - NCT00896740-97239
Conditions: Fanconi Anemia
Location: Portland, OR
- Hematopoiesis in Patients Receiving Gemcitabine and Platinum Therapy for Ovarian Cancer - NCT00771810-11718
Conditions: Thrombocytopenia - Neutropenia - Lymphopenia - Anemia
Location: Brightwaters, NY
- Hematopoiesis in Patients Receiving Gemcitabine and Platinum Therapy for Ovarian Cancer - NCT00771810-36604
Conditions: Thrombocytopenia - Neutropenia - Lymphopenia - Anemia
Location: Mobile, AL
- Hematopoiesis in Patients Receiving Gemcitabine and Platinum Therapy for Ovarian Cancer - NCT00771810-60612
Conditions: Thrombocytopenia - Neutropenia - Lymphopenia - Anemia
Location: Chicago, IL
- Hematopoiesis in Patients Receiving Gemcitabine and Platinum Therapy for Ovarian Cancer - NCT00771810-67208
Conditions: Thrombocytopenia - Neutropenia - Lymphopenia - Anemia
Location: Wichita, KS
- Hematopoiesis in Patients Receiving Gemcitabine and Platinum Therapy for Ovarian Cancer - NCT00771810-90033
Conditions: Thrombocytopenia - Neutropenia - Lymphopenia - Anemia
Location: Los Angeles, CA
- Hematopoiesis in Patients Receiving Gemcitabine and Platinum Therapy for Ovarian Cancer - NCT00771810-92868
Conditions: Thrombocytopenia - Neutropenia - Lymphopenia - Anemia
Location: Orange, CA
- Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine - NCT00987480-
Conditions: Aplastic Anemia - Leukemia - Myelodysplastic Syndrome
Location: Milwaukee, WI
- Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine - NCT00987480-02115
Conditions: Aplastic Anemia - Leukemia - Myelodysplastic Syndrome
Location: Boston, MA
- Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine - NCT00987480-10065A
Conditions: Aplastic Anemia - Leukemia - Myelodysplastic Syndrome
Location: New York, NY
- Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine - NCT00987480-10065B
Conditions: Aplastic Anemia - Leukemia - Myelodysplastic Syndrome
Location: New York, NY
- Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine - NCT00987480-45229
Conditions: Aplastic Anemia - Leukemia - Myelodysplastic Syndrome
Location: Cincinnati, OH
- Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and Fludarabine - NCT00595127-10065
Conditions: Fanconi Anemia
Location: New York, NY
- Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment - NCT00944749-20892
Conditions: Anemia, Aplastic - Anemia, Hypoplastic
Location: Bethesda, MD
- Identifying Characteristics of Bone Marrow Failure Syndromes - NCT00315419-17033
Conditions: Bone Marrow Failure Syndromes - Anemia, Aplastic - Myelodysplastic Syndromes - Hemoglobinuria, Paroxysmal - Red-Cell Aplasia, Pure - Purpura, Thrombocytopenic - Leukemia, Lymphocytic
Location: Hershey, PA
- Identifying Characteristics of Bone Marrow Failure Syndromes - NCT00315419-33612
Conditions: Bone Marrow Failure Syndromes - Anemia, Aplastic - Myelodysplastic Syndromes - Hemoglobinuria, Paroxysmal - Red-Cell Aplasia, Pure - Purpura, Thrombocytopenic - Leukemia, Lymphocytic
Location: Tampa, FL
- Identifying Characteristics of Bone Marrow Failure Syndromes - NCT00315419-44195
Conditions: Bone Marrow Failure Syndromes - Anemia, Aplastic - Myelodysplastic Syndromes - Hemoglobinuria, Paroxysmal - Red-Cell Aplasia, Pure - Purpura, Thrombocytopenic - Leukemia, Lymphocytic
Location: Cleveland, OH
- Identifying Characteristics of Bone Marrow Failure Syndromes - NCT00315419-90095
Conditions: Bone Marrow Failure Syndromes - Anemia, Aplastic - Myelodysplastic Syndromes - Hemoglobinuria, Paroxysmal - Red-Cell Aplasia, Pure - Purpura, Thrombocytopenic - Leukemia, Lymphocytic
Location: Los Angeles, CA
- Impact of Host Iron Status and Iron Supplement Use on Erythrocytic Stage of Plasmodium Falciparum - NCT01027663-27599
Conditions: Iron Deficiency Anemia - Malaria
Location: Chapel Hill, NC
- Impact of Maternal Iron Status on Neonatal Iron Status and Auditory Brainstem Response in the Newborn - NCT01019902-14642
Conditions: Anemia
Location: Rochester, NY
- Intelligent Control Approach to Anemia Management - NCT00572533-40202
Conditions: End-Stage Renal Disease
Location: Louisville, KY
- Investigation of the Cylex® ImmuKnow® Assay - NCT00569842-46202
Conditions: Leukemia - Non-Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Hodgkin's Disease - Multiple Myeloma - Myelodysplastic Syndromes - Myeloproliferative Disorders - Aplastic Anemia - Chronic Myelogenous Leukemia
Location: Indianapolis, IN
- Iron Prophylaxis for Anemia in Infants With Cyanotic Congenital Heart Disease - NCT00459225-30312
Conditions: Anemia
Location: Atlanta, GA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-01805
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Burlington, MA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-03431
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Keene, NH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-07018
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: East Orange, NJ
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-07112
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Newark, NJ
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-08043
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Voorhees, NJ
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-08240
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Pomona, NJ
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-10016
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: New York, NY
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-10461
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Bronx, NY
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-10466
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Bronx, NY
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-10940
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Middletown, NY
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-11501
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Mineola, NY
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-12801
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Glens Falls, NY
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-13057
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: East Syracuse, NY
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-16801
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: State College, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-16803
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: State College, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-17033
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Hershey, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-17043
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Lemoyne, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-17044
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Lewistown, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-17522
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Ephrata, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-17604
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Lancaster, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-17822
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Danville, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-18201
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Hazleton, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-18711
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Wilkes-Barre, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19001
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Abington, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19010
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Bryn Mawr, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19096A
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Wynnewood, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19096B
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Wynnewood, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19107
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Philadelphia, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19301
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Paoli, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19460
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Phoenixville, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19612
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Reading, PA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19713
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Newark, DE
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-19958
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Lewes, DE
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-21201
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Baltimore, MD
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-21231
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Baltimore, MD
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-21921
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Elkton Md, MD
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-22401
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Fredericksburg, VA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-22908
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Charlottesville, VA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-24115
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Martinsville, VA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-24541
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Danville, VA
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-25702
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Huntington, WV
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-26102
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Parkersburg, WV
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-26506
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Morgantown, WV
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-27534
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Goldsboro, NC
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-29615
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Greenville, SC
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-32207
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Jacksonville, FL
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-32224
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Jacksonville, FL
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-33021
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Hollywood, FL
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-33136
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Miami, FL
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-33612
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Tampa, FL
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-37916
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Knoxville, TN
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-39534
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Kessler AFB, MS
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-39581
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Pascagoula, MS
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43402
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Bowling Green, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43410
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Clyde, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43537A
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Maumee, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43537B
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Maumee, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43560
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Sylvania, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43567
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Wauseon, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43606
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Toledo, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43608
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Toledo, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43614
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Toledo, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43616A
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Oregon, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43616B
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Oregon, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43617
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Toledo, OH
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia - NCT00843882-43623A
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Toledo, OH
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|